Gossamer Bio, Inc.
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last report0 of 8 at or beyond impliedshaded = implied▲▼ = realized× = |realized| ÷ implied
−9.45%
vs ±71.9% implied · ×0.13
shaded = implied · ▲▼ = realized
Largest filed tie
100.00%
of GOSS revenue · Chiesi
No thesis.
Gossamer Bio, Inc.
10.20
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | D. E. ShawD. E. Shaw | $6.7M | 11.04% | +10417.73% | |
| 2 | 683 Capital Management683 Capital Management | $6.5M | 10.57% | +683.98% | |
| 3 | DeepCurrents Investment GroupDeepCurrents Investment | $6.0M | 9.87% | new | |
| 4 | Context Capital ManagementContext | $4.8M | 7.80% | new | |
| 5 | Worth Venture PartnersWorth Venture Partners | $4.1M | 6.74% | new | |
| 6 | AQR Capital ManagementAQR | $2.6M | 4.21% | +54.34% | |
| 7 | GSA Capital PartnersGSA Capital Partners | $2.5M | 4.04% | +360.54% | |
| 8 | Wolverine Asset ManagementWolverine | $2.1M | 3.48% | +143174.96% | |
| 9 | Renaissance TechnologiesRenaissance Technologies | $1.9M | 3.13% | +854.94% | |
| 10 | Kalehua Capital ManagementKalehua | $1.8M | 3.01% | +49.22% | |
| 11 | Vanguard Capital ManagementVanguardindex-like | $1.6M | 2.54% | +0.23% | |
| 12 | Arch VentureArch Venture | $1.3M | 2.17% | 0.00% | |
| 13 | BarclaysBarclays | $1.3M | 2.11% | +155.48% | |
| 14 | Octagon Capital AdvisorsOctagon Capital | $1.3M | 2.09% | 0.00% | |
| 15 | BlackRockBlackRockindex-like | $1.3M | 2.07% | −54.42% | |
| 16 | Arrowstreet Capital, Limited PartnershipArrowstreet Capital, Limited Partnership | $1.2M | 2.04% | new | |
| 17 | Two Sigma InvestmentsTwo Sigma | $1.2M | 2.00% | +55.45% | |
| 18 | Samsara BioCapitalSamsara BioCapital | $1.2M | 1.95% | 0.00% | |
| 19 | Qube Research & TechnologiesQube Research & Technologies | $1.2M | 1.90% | +43.68% | |
| 20 | CI Private WealthCI Private Wealth | $927,142 | 1.52% | +41.33% | |
| 21 | SirenSiren | $857,396 | 1.40% | 0.00% | |
| 22 | Hillhouse Capital AdvisorsHillhouse Capital | $818,727 | 1.34% | 0.00% | |
| 23 | UBS GroupUBS | $510,474 | 0.84% | +64.25% | |
| 24 | Squarepoint OpsSquarepoint Ops | $420,780 | 0.69% | −24.78% | |
| 25 | Geode Capital ManagementGeodeindex-like | $408,706 | 0.67% | −49.76% |
169 managers report $61.1M of Gossamer Bio on form 13F for the quarter ended Jun 30 '26. 18 of them hold 80% of it; D. E. Shaw is largest at 11.04%.
No implied move.
No implied move.
Expected move
No implied move.